Exhibit 3.3
CERTIFICATE OF AMENDMENT
OF THE
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
OF
THRESHOLD PHARMACEUTICALS, INC.
The undersigned, Dr. Harold E. Selick, hereby certifies that:
1. He is the Chief Executive Officer of Threshold Pharmaceuticals, Inc., a Delaware corporation (the Corporation).
2. The original Certificate of Incorporation was filed with the Secretary of State of the State of Delaware on October 17, 2001.
3. Article Fourth, Paragraph A of the Corporations Amended and Restated Certificate of Incorporation is amended and restated in its entirety to read as follows:
A. The total number of shares of all classes of stock which the Corporation shall have authority to issue is 152,000,000, consisting of 150,000,000 shares of Common Stock, par value $0.001 per share (the Common Stock) and 2,000,000 shares of Preferred Stock, par value $0.001 per share (the Preferred Stock).
4. This Certificate of Amendment of the Corporations Amended and Restated Certificate of Incorporation has been duly adopted by this Corporations Board of Directors and stockholders in accordance with the provisions of the Corporations Amended and Restated Certificate of Incorporation and with Section 242 of the General Corporation Law of the State of Delaware.
IN WITNESS WHEREOF, the undersigned has executed this Certificate of Amendment of Amended and Restated Certificate of Incorporation at Redwood City, California on May 25, 2010.
/s/ Harold E. Selick |
Harold E. Selick, Ph.D. Chief Executive Officer |